Kiniksa Pharmaceuticals Announces Closing of Global License Agreement with Genentech for Vixarelimab

Source :: GlobeNewswire. September 12, 2022
Publication Year :: 2022
Abstract: HAMILTON, Bermuda, Sep 12, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:KNSA), EQNX::TICKER_END Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio of assets designed to modulate [...]

Subjects :: Roche Holding AG -- Licensing agreements
Biological products industry -- Licensing agreements
Biotechnology industry -- Licensing agreements
Monoclonal antibodies
Company licensing agreement
Banking, finance and accounting industries
Business

Tools